Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis

NCT04680975 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision due to slow enrollment and strategic consideration; not driven by any safety concerns.

Conditions

Interventions

Sponsor

Kadmon, a Sanofi Company